Delivery Order SPE2DB24D3013-SPE2DB24FFJCS
Award Date
9/27/24
Potential Completion Date
9/30/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a ceiling value of $1,557.48 and a completion date of January 29, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The $4,208.32 firm fixed price contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin product. The delivery order falls under an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,903.37 firm fixed-price contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication, with a ceiling value of $1,084.59 and a performance period ending on March 6, 2025. The contract is a firm-fixed-price delivery order, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication, with a ceiling value of $1,548.12 and a period of performance through April 1, 2025. The contract is a delivery order placed under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,925.76, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a brand-name insulin medication. The contract is a firm-fixed-price, delivery order type with an ultimate completion date of April 19, 2024. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,750.14, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of April 4, 2025. The contract was awarded on April 3, 2025 and does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $2,123.49 and a performance period through May 9, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific socioeconomic program. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $1,758.48 and a period of performance through May 14, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has a ceiling value of $1,970.64 and is a firm fixed-price, non-set-aside contract with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...